Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 3
---
 refund in the event that we do not sell an amount of securities sufficient to
pursue our business goals described in this prospectus. In addition, because there is no escrow account and no minimum offering amount,
investors could be in a position where they have invested in our company, but we are unable to fulfill all of our contemplated objectives
due to a lack of interest in this offering.

Certain of our officers and directors have agreed to purchase an aggregate
of 510,200 Pre-Funded Warrants and accompanying Common Warrants to purchase 510,200 shares of Common Stock, for a total purchase price
of approximately $1,000,000 at the public offering price and on the same terms as the other purchasers in this offering.

Further, any proceeds from the sale of securities offered by us will
be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our
business plan. We will bear all costs associated with the offering. The table set forth below excludes an additional $0.0588 per share
or Pre-Funded Warrant and accompanying Offered Common Warrant ($150,000 in the aggregate) in fees payable to our financial advisor. See
“Plan of Distribution” on page 184 of this prospectus for more information regarding these arrangements.

|                                  |     | Per Share   
 and Offered 
 Common      
 Warrant     |        |     | Per         
 Pre-Funded  
 Warrant and 
 Offered     
 Common      
 Warrant     |          |     | Total |           |
|:---------------------------------|:----|:------------|-------:|:----|:------------|---------:|:----|:------|----------:|
| Public offering price            |     | $           | 1.9600 |     | $           |   1.9599 |     | $     | 5,000,000 |
| Placement agent fees(1)          |     | $           | 0.1764 |     | $           | 0.176391 |     | $     |   400,000 |
| Proceeds, before expenses, to us |     | $           | 1.7836 |     | $           | 1.783509 |     | $     | 4,600,000 |

| (1) | Includes a cash fee up to 9% of the gross proceeds raised in this offering; provided, however, the cash                 
 fee shall equal